Maju Mathews Selected Research

Paliperidone Palmitate

1/2021	Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis.
1/2021	Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate.
1/2020	Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks' Treatment in Patients with Clinically Stable Schizophrenia.
1/2020	Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study.
1/2020	Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies.
1/2020	Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes.
1/2020	Patients' Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire.
1/2020	Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia.
11/2019	Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month Formulations.
11/2019	Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maju Mathews Research Topics

Disease

28	Schizophrenia (Dementia Praecox) 01/2021 - 02/2005
13	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2004
5	Anxiety Disorders (Anxiety Disorder) 01/2017 - 06/2015
4	Psychomotor Agitation (Akathisia) 01/2019 - 06/2015
4	Weight Gain 01/2017 - 06/2015
4	Nausea 12/2016 - 11/2014
4	Diarrhea 12/2016 - 11/2014
3	Treatment-Resistant Depressive Disorder 01/2022 - 01/2020
3	Neuroleptic Malignant Syndrome 03/2019 - 01/2006
3	Sleepiness 01/2018 - 06/2015
3	Mania (Manias) 01/2018 - 01/2016
3	Dizziness (Lightheadedness) 01/2017 - 06/2015
3	Fatigue 12/2016 - 01/2014
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2016 - 01/2007
3	Psychotic Disorders (Schizoaffective Disorder) 07/2009 - 01/2007
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2017 - 06/2015
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017 - 03/2015
2	Vomiting 06/2015 - 03/2015
1	Dyskinesias (Dyskinesia) 01/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2019
1	Tremor (Tremors) 01/2019
1	Pain (Aches) 10/2018
1	Injection Site Reaction 10/2018
1	Hypesthesia (Numbness) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Dysgeusia (Parageusia) 01/2017
1	Ejaculatory Dysfunction 12/2016
1	Erectile Dysfunction 12/2016
1	Hyperprolactinemia 07/2009
1	Pituitary Neoplasms (Pituitary Adenoma) 07/2009
1	Prolactinoma (Prolactinomas) 07/2009
1	Opioid-Related Disorders (Opiate Addiction) 03/2007
1	Sialorrhea 01/2007
1	Autistic Disorder (Autism) 03/2006
1	Thrombocytopenia (Thrombopenia) 01/2006
1	Mental Disorders (Mental Disorder) 11/2005
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2005
1	Movement Disorders (Movement Disorder) 03/2005

Drug/Important Bio-Agent (IBA)

25	Paliperidone Palmitate FDA Link 01/2021 - 10/2016
13	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 03/2005
11	Vilazodone HydrochlorideIBA 01/2017 - 01/2014
7	asenapine FDA Link 01/2018 - 06/2015
4	EsketamineIBA 01/2022 - 01/2020
4	Risperidone (Risperdal Consta)FDA LinkGeneric 08/2018 - 02/2005
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2016 - 03/2015
3	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2021
3	Nasal SpraysIBA 01/2022 - 01/2021
3	Aripiprazole (Abilify)FDA Link 01/2018 - 03/2007
3	5-HT1A Serotonin ReceptorIBA 12/2016 - 06/2015
2	Olanzapine (Zyprexa)FDA Link 01/2017 - 01/2017
1	BenzodiazepinesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	LithiumIBA 01/2017
1	Citalopram FDA LinkGeneric 07/2015
1	Glucose (Dextrose)FDA LinkGeneric 06/2015
1	Serotonin (5 Hydroxytryptamine)IBA 11/2014
1	Haloperidol (Haldol)FDA LinkGeneric 07/2009
1	ProlactinIBA 07/2009
1	Dopamine Agonists (Dopamine Agonist)IBA 07/2009
1	Buprenorphine (Subutex)FDA LinkGeneric 03/2007
1	Acetylcarnitine (Alcar)IBA 01/2007
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2007
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2006
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2006
1	Sertraline (Zoloft)FDA LinkGeneric 01/2004

Therapy/Procedure

16	Injections 01/2021 - 10/2016
2	Therapeutics 01/2020 - 01/2017
2	Secondary Prevention 01/2020 - 01/2019
1	Transcranial Magnetic Stimulation 11/2005